22 Apr 2013 07:00
FOR IMMEDIATE RELEASE
Â
London, 22 April 2013
Â
Â
Â
Annual Report and Accounts
Notice of Annual General Meeting: 23 May 2013
Â
ImmuPharma PLC (AIM:IMM) (the "Company") the specialist drug discovery and development company, confirms that the Annual Report and Accounts for the year ended 31 December 2012 has been posted to shareholders.
Â
The Annual Report is available, in electronic form, for download on the Company's website www.immupharma.com.
Â
The Company's Annual General Meeting will be held on 23 May 2013 at 11:00am at the offices of Bircham Dyson Bell LLP, 50 Broadway, London, SW1H 0BL.
Â
Â
For further information please contact:
Â
ImmuPharma PLC
Â
Richard Warr, Chairman +44 20 7152 4080
Dimitri Dimitriou, Chief Executive Officer +44 20 7152 4080
Lisa Baderoon, Head of Investor Relations +44 7721 413 496
Â
Panmure Gordon & Co., NOMAD & Broker +44 20 7886 2500
Hugh Morgan, Fred Walsh, Hannah Woodley
Â